The latest vaccine to go to phase 3 testing may still emerge among the first to reach public use
On Tuesday, consumer pharmaceutical giant Johnson & Johnson announced that their vaccine for COVID-19 was entering phase 3 trials. It seems hard to get excited about yet another vaccine at this point, especially when others began their phase 3 trials weeks, or even months, ago.